In CRC, miR-20 influences the activation of the cyclin-dependent kinase inhibitor 1A/p21 (CDKN1A/p21), which negatively regulates TGFβ, thus preventing its antiproliferative effect [286]. This evidence concerns the gene TGFB1 and colorectal carcinoma.